Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) is one of 896 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its peers? We will compare Jaguar Animal Health to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, earnings, dividends and valuation.
Earnings and Valuation
This table compares Jaguar Animal Health and its peers gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Jaguar Animal Health | $11.51 million | -$53.43 million | -0.00 |
| Jaguar Animal Health Competitors | $5.44 billion | $3.22 billion | 552.59 |
Jaguar Animal Health’s peers have higher revenue and earnings than Jaguar Animal Health. Jaguar Animal Health is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Institutional & Insider Ownership
12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 32.7% of shares of all “Pharmaceuticals” companies are held by institutional investors. 0.1% of Jaguar Animal Health shares are held by company insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings and target prices for Jaguar Animal Health and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Jaguar Animal Health | 1 | 0 | 0 | 0 | 1.00 |
| Jaguar Animal Health Competitors | 7798 | 13891 | 25790 | 1038 | 2.41 |
As a group, “Pharmaceuticals” companies have a potential upside of 24.66%. Given Jaguar Animal Health’s peers stronger consensus rating and higher probable upside, analysts clearly believe Jaguar Animal Health has less favorable growth aspects than its peers.
Profitability
This table compares Jaguar Animal Health and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Jaguar Animal Health | -187.88% | N/A | -131.45% |
| Jaguar Animal Health Competitors | -2,380.39% | -218.78% | -15.59% |
Risk and Volatility
Jaguar Animal Health has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500. Comparatively, Jaguar Animal Health’s peers have a beta of -3.79, meaning that their average share price is 479% less volatile than the S&P 500.
Summary
Jaguar Animal Health peers beat Jaguar Animal Health on 10 of the 13 factors compared.
Jaguar Animal Health Company Profile
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company's products include Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing NP-300, a second-generation antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.
Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
